OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Respiratory Journal
DOI: 10.1183/09031936.00225511
Authors: Paul W. Jones, Dave Singh, Eric D. Bateman, Alvar Agusti, Rosa Lamarca, Gonzalo de Miquel, Rosa Segarra, Cynthia Caracta, Esther Garcia Gil
Institutions: St George's, University of London, University of Manchester, Medicines Evaluation Unit, University of Cape Town, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Universitat de Barcelona, Almirall (Spain), Forest Laboratories (United States)
Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: aclidinium bromide, chronic obstructive pulmonary disease, twice-daily dosing, anticholinergic agents, bronchodilation, FEV1, health status, St George's Respiratory Questionnaire, dyspnea, anticholinergic adverse events, drug safety
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2171697174
FWCI: 23.03
Cites: 20
Cited by: 197
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security